A single split-signal FISH probe set allows detection of TAL1 translocations as well as SIL-TAL1 fusion genes in a single test M van 
Introduction
Up to 30% of T cell acute lymphoblastic leukemias (T-ALL) have aberrations in the TAL1 gene (T cell acute leukemia gene 1) in chromosome region 1p32, also called SCL or TCL5. 1, 2 These aberrations result in ectopic TAL1 protein expression. In another group of T-ALL (ෂ30%), TAL1 protein is also ectopically expressed in the blasts, but in these T-ALL no apparent TAL1 gene abnormality has been found. 2, 3 TAL1 is normally expressed in pluripotent hematopoietic precursors, mast cells, megakaryocytes and maturing erythroid cells, but not in lymphoid cells. 4 Studies on TAL1 knock out mice show that TAL1 is required for embryonic and adult hematopoiesis, as well as for terminal erythroid differentiation. [5] [6] [7] TAL1 belongs to the basic helix-loop-helix (bHLH) family of transcription factors and can form heterodimers with more widely expressed bHLH proteins referred to as E proteins. 8 alone does not have DNA binding capacity, but can bind as a heterodimer with, for example, E2A. 9 Lim-only protein genes, LMO1 and LMO2, are also frequently involved in chromosome aberrations in T-ALL. 10 The heterodimer of TAL1 and E2A appeared to interact with LMO proteins in an oligomeric transcription complex. 11, 12 These ectopically expressed TAL1 and LMO proteins have been shown to exert their oncogenic effect through inhibition of E2A activity in leukemic T cells. [13] [14] [15] The majority of TAL1 gene aberrations comprise intrachromosomal submicroscopic deletions of 90 kb in region 1p32 with an incidence of 12-26% in childhood T-ALL. [16] [17] [18] This deletion removes all coding exons of the SIL (SCL interrupting locus) gene and the 5Ј untranslated region of the TAL1 gene, placing the TAL1 coding region under direct control of the SIL promoter. As the SIL gene is ubiquitously expressed, this socalled SIL-TAL1 fusion gene transcript results in ectopic TAL1 expression in T cells. 19 The SIL-TAL1 fusion gene is restricted to CD3 + TCR␣␤ + T-ALL and to CD3 − T-ALL with TCRD deletions that are developing into the TCR␣␤-lineage. 20, 21 In the SIL gene, three deletion breakpoints (sildb1 to 3) have been identified, of which sildb1 is most frequently used (95%). 16, 18, 22 The TAL1 gene contains seven deletion breakpoints (taldb1 to 7), with two being involved in 98% of cases (taldb1 and 2). 17, 18, 20, [22] [23] [24] [25] In 3% of T-ALL, ectopic TAL1 expression is caused by t(1;14)(p32;q11). 26 This translocation involves the T cell receptor delta (TCRD) locus at chromosome 14q11, which replaces the non-coding 5Ј part of the TAL1 gene. 27 As a result of t (1;14) , the TAL1 gene is controlled by the regulatory elements of the TCRD gene, resulting in ectopic TAL1 expression. Three additional rare TAL1 translocations have been reported: t(1;7)(p32;p35) involving the TCRB locus, with a breakpoint 35 kb downstream of the TAL1 coding sequences; 28 t(1;3)(p32;p21) involving the TCTA gene; 1,29 and t(1;5)(p32;q31) of which the exact partner gene has not yet been identified. 30 Like in t (1;14) , the breakpoints in t(1;3)(p32;p21) and t(1;5)(p32;q31) are located in the 5Ј untranslated region of the TAL1 gene. Although aberrations in the TAL1 gene are the most common defect in T-ALL, no clear correlation was found in a large series of 182 children with newly diagnosed T-ALL between TAL1 gene aberrations and clinical outcome. 24 Kikuchi et al, 31 however, suggested that the presence of SIL-TAL1 fusion genes is correlated with a good prognosis. TAL1 aberrations are at least partly mediated via aberrant V(D)J recombinase activity as became apparent by the presence of recombination signal sequence (RSS)-like motifs close to the breakpoints, and 'classic' junctional regions with nontemplated nucleotides (N-regions), P-region nucleotides, and deletion of nucleotides by exonuclease activity. 16, 20 Several techniques have been used for detecting TAL1 gene aberrations. Although TAL1 translocations can be detected via conventional karyotyping, microdeletions resulting in SIL-TAL1 fusion genes cannot be detected with this technique. Instead, PCR at the DNA level or RT-PCR is used for the detection of the various types of SIL-TAL1 fusion genes. 18, 20, 25 However, PCR-based detection of TAL1 translocations is not possible, because of the various partner genes involved and because of the large breakpoint regions. Therefore, we designed a split-signal FISH probe set for the detection of SIL-TAL1 fusion genes, as well as TAL1 translocations.
Materials and methods

Patient samples and cell lines
For the present study, 16 T-ALL patient samples were selected. TAL1 protein expression was determined on cytocentrifuge preparations with TAL1 monoclonal antibodies BTL073 and TWN60 using fluorescence microscopy. 32, 33 Furthermore, the presence of SIL-TAL1 fusion transcripts was determined by RT-PCR analysis. 25 In cases with detectable SIL-TAL1 fusion transcripts, TAL1 deletion breakpoints were identified by PCR analysis followed by sequencing. 20, 34 Cytogenetic analysis was performed at diagnosis on freshly obtained bone marrow or peripheral blood cells, which were cultured and harvested according to routine cytogenetic procedures. Chromosomes were described according to the convention of the International System for Human Cytogenetic Nomenclature (ISCN 95). The patient characteristics are summarized in Table 1 . Cell lines MOLT17 and DU528 were used as positive controls for detection of the SIL-TAL1 fusion gene and the TAL1 translocation t(1;14)(p32;q11), respectively. 20, 27, 35, 36 Inclusion and exclusion probes for selection of PAC and cosmid clones PCR-based screening probes were developed in the SIL-TAL1 region, using DNA of a healthy control as template (see Figure  1 ). PCR conditions were: 10 min at 94°C to activate the AmpliTaq Gold polymerase (Applied Biosystems, Foster City, CA, USA) followed by 1 min at 94°C, 1 min at 60°C, and 2 min at 72°C for 35 cycles. The PCR products were analyzed on a 1% agarose gel.
Library screening and PAC/cosmid isolation
Human PAC library RPCI1 (UK HGMP Resource Center, Cambridge UK) and chromosome 1 specific cosmid library 112 (L4/FS1) (Resourcezentrum im Deutschen Humangenomprojekt RZPD, Berlin, Germany) were hybridized with the 32 PdATP and 32 P-dCTP labeled SIL15, 3ЈTAL41, and 3ЈTAL55 inclusion probes. Positive clones were ordered as bacterial colonies, which were subsequently cultured according to the manufacturer's instructions. The PAC or cosmid DNA was isolated using an alkaline lysis protocol. 37 
Fluorescent in situ hybridization (FISH)
Dual-colored FISH was performed with FISH probes, which were labeled by nick-translation with either biotin-16-dUTP or digoxigenin-11-dUTP (Boehringer Mannheim, Mannheim, Germany). For FISH analysis, leukemic preparations stored at −20°C for up to several years or freshly prepared preparations from −20°C stored methanol/acetic acid-fixed cell suspensions were used. FISH was carried as previously described. 38 Two independent observers each blindly scored 200 interphase cells per sample.
Results and discussion
In order to be able to detect SIL-TAL1 fusion genes, as well as TAL1 translocations, in a single FISH test, two FISH probes are required. The upstream FISH probe should be positioned in the 90 kb region that is deleted during a SIL-TAL1 fusion, ie downstream of the deletion breakpoints in the SIL gene and upstream of the deletion and translocation breakpoints in the TAL1 gene. The downstream probe has to be positioned downstream of the TAL1 breakpoints. In cases with SIL-TAL1 fusion genes, the upstream probe will be lost giving rise to one separate green signal of the downstream probe and one co-localized (green/red) signal of the unaffected SIL-TAL1 region. A TAL1 translocation will result in a split-signal (one red (R) and one green (G) signal) together with a colocalized signal.
Definition of inclusion and exclusion regions for probe design
For selection of the optimal FISH probes, inclusion and exclusion regions were defined: the FISH probes were selected for positivity for the inclusion regions, whereas exclusion regions were defined to mark the border of the FISH probes. PCR-based inclusion probes were designed in SIL intron 15 (SIL15) and 41 kb downstream of the last exon of the TAL1 gene (3ЈTAL41) (see Figure 1) . To include detection of the rare t(1;7) breakpoint in this FISH assay, an extra inclusion probe was designed 55 kb downstream of TAL1 (3ЈTAL55), with potential risk that the inter-probe distance might become too large for co-localization of signals. 28 Exclusion regions for the upstream FISH probe were SIL exon 1 (SIL1) and the region 9 kb upstream of the TAL1 gene (5ЈTAL9). The last TAL1 exon (TAL6) was used as exclusion region for the downstream FISH probe. In addition, 3ЈTAL41 was used as exclusion probe in combination with 3ЈTAL55 as inclusion probe for detection of t(1;7) breakpoints ( Figure 1) .
All primer sets were tested on DNA of a healthy control. All combinations except for the primers for 3ЈTAL55 gave single PCR products. The two 3ЈTAL55 amplification products were sequenced. The first PCR product was located as expected 55 kb downstream of the TAL1 gene, whereas the other PCR product appeared to be derived from sequences 33 kb downstream of the 3ЈTAL55 region, and will hereafter be referred to as 3ЈTAL55a. 
Library screening
The chromosome 1 specific cosmid library and the human PAC library were screened with the inclusion probes (SIL15, 3ЈTAL41, 3ЈTAL55/3ЈTAL55a) to select cosmid and PAC clones that could potentially be used as FISH probes. One PAC clone, but no cosmid clones, was identified with SIL15. PCR analysis was used for further positioning and showed negativity for the SIL1 and 5ЈTAL9 exclusion regions. Therefore, this clone is exactly located within the defined region, which is deleted in case of a SIL-TAL1 fusion gene, and will hereafter be referred to as SIL-U probe.
Three PAC clones were identified with 3ЈTAL55/3ЈTAL55a. One cosmid clone was found to be only positive for 3ЈTAL41; another cosmid clone was only positive for 3ЈTAL55. Five overlapping clones identified with 3ЈTAL41 and 3ЈTAL55 were not further tested.
Testing of the FISH probes
SIL-U was used in combination with each of the three PAC clones in the TAL1 region on cells of a healthy donor and on cell lines MOLT17 and DU528. These combinations of probes would in principle allow detection of all types of SIL-TAL1 fusion genes, as well as all described TAL1 translocations, including the rare t (1;7) . In cells of a healthy donor two colocalized (green and red) signals were present representing two intact gene regions using all three combinations. However, two of the three TAL1 PAC clones gave additional signals on the q arm of chromosome 1 due to homologous sequences and were therefore omitted from further analyses. The distance between the two signals of the SIL-U probe and the remaining TAL1 PAC was too large in about 5% of the cells of a healthy donor, resulting in seemingly split-signals (ie false positivity). To shorten the distance between the two probes, we extended the downstream probe with the more upstreamlocated cosmid clone, which was positive for 3ЈTAL41. The other TAL1 cosmid clone, which was positive for 3ЈTAL55, gave additional signals on the q arm of chromosome 1, as was also observed with two of the TAL1 PAC clones, and was not further used. For all further FISH analyses SIL-U was used as upstream probe in combination with the TAL1-D probe, which consists of a cosmid and a PAC clone (Figure 1 ).
In cells with a SIL-TAL1 fusion gene, the upstream probe (SIL-U) was lost, resulting in one single green signal of the downstream FISH probe (TAL1-D) of the allele with the SIL-TAL1 fusion gene and one co-localized signal of the intact SIL-TAL1 gene region (Figure 2c) . A theoretical limitation might be that also larger deletions can be detected, ie deletions spanning the SIL promoter region. In these cases, the TAL1 gene is not placed under control of an active promoter and will not be expressed. The frequency of such events will most probably be rather low, as no larger deletions have been reported in the literature and also in this study, we did not identify T-ALL with SIL gene deletions, but without TAL1 protein expression (see below). However, to fully exclude the occurrence of extensive deletions in the SIL locus, a larger series of T-ALL would have to be analyzed with the split-signal probes in parallel with evaluation of TAL1 protein expression.
In case of a TAL1 translocation, the two FISH probes gave rise to a split-signal, ie a single red and a single green signal together with one co-localized signal of the unaffected chromosome 1p32 region. Figure 2d shows DU528 cells with t (1;14) . This probe set allows detection of all TAL1 gene translocations, irrespective of the involved partner gene, as long as the translocation breakpoint does not overlap with either the upstream or downstream FISH probes. As the downstream FISH probe had to be extended with a cosmid, this might hamper the detection of putative breakpoints downstream of the TAL1 gene, similar to the so far single reported t(1;7), because the translocation breakpoint in such cases is located within the TAL1-D probe. 28 The TAL1 FISH probes are available via DAKO A/S (Dr T Poulsen/Dr K Vang Nielsen, Produktionsvej 42, DK-2600 Glostrup, Denmark).
Detection of SIL-TAL1 fusion genes and TAL1 translocations in T-ALL patients
The SIL-U and TAL1-D probes were subsequently tested on a series of 16 T-ALL samples. T-ALL-1 to T-ALL-4 did not express TAL1 protein, did not show cytogenetic aberrations in the chromosome region 1p32, and no SIL-TAL1 fusion tran- T-ALL-5 to T-ALL7 expressed TAL1 protein, but did not show PCR-detectable SIL-TAL1 fusion transcripts. Using our TAL1 probe set, we confirmed that the SIL-TAL1 region in these T-ALL was intact. So we conclude that these three T-ALL cases belong to the category of TAL1 protein expression in blasts in the absence of a TAL1 gene aberration. 2, 24 In T-ALL-8 to T-ALL-14, SIL-TAL1 fusion transcripts were detected via RT-PCR and material was available to identify TAL1 protein expression in cases T-ALL-9 to T-ALL-14. With FISH analysis, the SIL-TAL1 fusion could be confirmed in all cases by the presence of a single green signal. T-ALL-14 is shown as a representative case in Figure 2e .
In cells of T-ALL-15 and T-ALL-16, one co-localized signal together with separate green and red signals were identified, representing TAL1 translocations (T-ALL-15 depicted in Figure  2f ). The inherent advantage of using this split-signal FISH approach is that the detection of the TAL1 translocations is independent of the partner chromosome or partner gene. 38, 39 The partner chromosome or partner gene of TAL1 is not yet known in T-ALL-15. Molecular analysis is currently being performed to identify and further characterize the partner gene of this TAL1 translocation (AW Langerak et al, unpublished results). T-ALL-16 has been described to harbor a t(1;5)(p32;q35). 30 
Determination of cut-off values
An advantage of split-signal FISH probes is the avoidance of high levels (5-10%) of false-positivity due to coincidental coLeukemia localization, which is observed with fusion FISH probes that co-localize in case of a chromosome aberration. 40 Split-signal FISH can only give rise to low frequencies of false-negativity due to coincidental co-localization of signals. However, 5-10% false-negativity within the leukemic cell population will not alter the result in diagnostic material. The cut-off values were determined using the data of T-ALL samples without a TAL1 gene aberration (T-ALL-1 to T-ALL-7). The cut-off value for the translocation (RG/R/G, Table 1 ), defined as the mean value of the seven T-ALL samples plus three times the standard deviation, was 1.8%. The cut-off value for the SIL-TAL1 fusion gene resulting in the deletion of the SIL-U probe (RG/G) was 1.4%.
Conclusions
We developed a TAL1 FISH probe set based on the split-signal FISH principle, which allows reliable detection of SIL-TAL1 fusion genes, as well as TAL1 translocations in a single test. Together with the application of molecular techniques such as pan-handle PCR analysis, this may lead to the identification of new TAL1 partner genes.
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